STVN | Stevanato Group S.p.A. Stock Overview

(Stock Exchange: NYSE)

Day's Range	19.13 - 19.70
52 Week Range	16.56 - 35.56
Beta	0.53
Implied Volatility	51.05%
IV Rank	46.63%
Day's Volume	595,685
Average Volume	571,545
Shares Outstanding	272,683,970
Market Cap	5,254,620,102
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	2021-07-16

Valuation
Profitability
Growth
Health
P/E Ratio	37.78
Forward P/E Ratio	N/A
EPS	0.51
1YR Price Target	N/A
Dividend Yield	0.30%
Dividend Per Share	0.06
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	5,635
Country	Italy
Website	STVN

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

STVN's peers: RYAN, HAE, MMSI, ANGO, ATR, NVST, ICUI, COO, TFX, WST, ALC, RMD, XRAY, ATRC, AKYA

*Chart delayed

Analyzing fundamentals for STVN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is very poor, Growth is bad and Health is weak. For more detailed analysis please see STVN Fundamentals page.

Watching at STVN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on STVN Technicals page.